CONTACT:
Jeanan Yasiri Moe
Director of Strategic Communications
[email protected]
608.890.1491

MADISON, Wis. – Several new initiatives recently announced by WARF – including two venture capital funds and a program to bring new pharmaceuticals closer to market – will have powerful implications for UW–Madison and the state.

Managing Director Erik Iverson will reflect on these changes and more at “WARF’s Plans for Advancing Innovation and Entrepreneurship: What it means for campus and Wisconsin” to be held Tue., Oct. 3, at the Discovery Building beginning at 4 p.m. The event is free and open to faculty, staff, students and the public.

The event caps a summer of engagement for Iverson, in which he discussed WARF’s plans to increase spending on UW-affiliated startups and drug discovery. His address will be followed by a conversation with leaders from the local entrepreneurial and venture communities.

Panelists to include:
Rock Mackie, UW–Madison & Association of Campus Entrepreneurs (ACE)
Tom Still, Wisconsin Technology Council
John Neis, Venture Investors

Please register for this event by Friday, September 29.

About WARF
The Wisconsin Alumni Research Foundation (WARF) helps steward the cycle of research, discovery, commercialization and investment for the University of Wisconsin–Madison. Founded in 1925 as an independent, nonprofit foundation, WARF manages more than 1,700 patents and an investment portfolio of $2.6 billion as it funds university research, obtains patents for campus discoveries and licenses inventions to industry. For more information, visit warf.org.

###